Kaliumchloride + Glucose Fresenius Kabi

Potassium chloride, the active ingredient in Kaliumchloride + Glucose Fresenius Kabi, is an electrolyte supplement presented as an injection solution for intravenous use. It treats hypokalemia and supports fluid and electrolyte replacement in patients requiring potassium repletion.

GNH USA supplies Kaliumchloride + Glucose Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kaliumchloride + Glucose is used in electrolyte management and correction of potassium deficits.

- Hypokalemia: restores serum potassium to normal levels in patients with low potassium. - Potassium depletion: corrects intracellular potassium deficit during intensive care or surgery. - Fluid and electrolyte replacement: provides potassium and an energy source to maintain electrolyte balance during IV therapy.

Kaliumchloride + Glucose may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: discomfort at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Hyperglycemia: elevated blood glucose levels, especially in diabetic patients. - Nausea: feeling of sickness or urge to vomit. - Mild hyperkalemia: modest rise in serum potassium if over‑corrected.

Serious or Rare Side Effects: - Cardiac arrhythmias: irregular heart rhythm due to potassium imbalance. - Severe hyperkalemia: dangerous elevation of serum potassium that can impair cardiac function. - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Tissue necrosis: damage to tissue if the solution extravasates from the vein.

Before using Kaliumchloride + Glucose, clinicians should consider several safety measures.

- Serum potassium assessment: verify baseline potassium levels prior to infusion. - Cardiac monitoring: observe ECG for arrhythmias during and after administration. - Renal function evaluation: adjust dose in patients with impaired kidney clearance. - Infusion rate control: avoid rapid administration to reduce risk of hyperkalemia. - Aseptic technique: use sterile equipment and follow infection‑control protocols. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the container.

Kaliumchloride + Glucose can interact with other medicines that affect potassium balance or glucose metabolism.

Major Interactions (Avoid): - ACE inhibitors: may increase serum potassium and precipitate hyperkalemia. - Potassium‑sparing diuretics: additive effect on potassium levels. - NSAIDs: can reduce renal potassium excretion, raising risk of hyperkalemia. - IV calcium gluconate: may precipitate when mixed with potassium chloride.

Moderate Interactions (Monitor Closely): - Beta‑blockers: can blunt cellular potassium shifts. - Digoxin: elevated potassium may enhance digoxin toxicity. - Insulin therapy: insulin drives potassium into cells, affecting serum levels. - Loop or thiazide diuretics: increase potassium loss, requiring careful monitoring.